Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John W Holloway

Showing results (1-10 of 268) with videos related to

Pageof 27
Sort By:
New Zealand Bioethics Journal|December 14, 2004
In that case. A multi-national pharmaceutical company wishes to recruit some of your patients to a pharmaco-genetic study. ResponseJohn W Holloway
The Journal of Allergy and Clinical Immunology|May 4, 2005
Beta2-Adrenergic receptor polymorphism and asthma: true or false?John W Holloway, Ian A Yang
Paediatric Respiratory Reviews|January 3, 2012
Successful grant writingGerard H Koppelman, John W Holloway
American Journal of Respiratory and Critical Care Medicine|May 24, 2022
Omics and Lung Function: A Need for IntegrationJohn W Holloway, Dawn L DeMeo
Chemical Immunology and Allergy|October 22, 2004
GeneticsJohn W Holloway, Stephen T Holgate
The New England Journal of Medicine|October 17, 2008
17q21 variants and asthma - questions and answersJohn W Holloway, Gerard H Koppelman
Current Opinion in Allergy and Clinical Immunology|January 16, 2007
Identifying novel genes contributing to asthma pathogenesisJohn W Holloway, Gerard H Koppelman
Current Opinion in Allergy and Clinical Immunology|August 16, 2013
Genome-wide association studies in asthma; perhaps, the end of the beginningGabrielle A Lockett, John W Holloway
BMC Pulmonary Medicine|November 6, 2013
Altered microRNA expression profile during epithelial wound repair in bronchial epithelial cellsAleksandra Szczepankiewicz, Peter M Lackie, John W Holloway
Atherosclerosis|September 6, 2003
TLR4 Asp299Gly polymorphism is not associated with coronary artery stenosisIan A Yang, John W Holloway, Shu Ye, et al.
Pageof 27

Showing results (1-10 of 268) with videos related to

Sort By:
Pageof 27
New Zealand Bioethics Journal|December 14, 2004
In that case. A multi-national pharmaceutical company wishes to recruit some of your patients to a pharmaco-genetic study. ResponseJohn W Holloway
The Journal of Allergy and Clinical Immunology|May 4, 2005
Beta2-Adrenergic receptor polymorphism and asthma: true or false?John W Holloway, Ian A Yang
Paediatric Respiratory Reviews|January 3, 2012
Successful grant writingGerard H Koppelman, John W Holloway
American Journal of Respiratory and Critical Care Medicine|May 24, 2022
Omics and Lung Function: A Need for IntegrationJohn W Holloway, Dawn L DeMeo
Chemical Immunology and Allergy|October 22, 2004
GeneticsJohn W Holloway, Stephen T Holgate
The New England Journal of Medicine|October 17, 2008
17q21 variants and asthma - questions and answersJohn W Holloway, Gerard H Koppelman
Current Opinion in Allergy and Clinical Immunology|January 16, 2007
Identifying novel genes contributing to asthma pathogenesisJohn W Holloway, Gerard H Koppelman
Current Opinion in Allergy and Clinical Immunology|August 16, 2013
Genome-wide association studies in asthma; perhaps, the end of the beginningGabrielle A Lockett, John W Holloway
BMC Pulmonary Medicine|November 6, 2013
Altered microRNA expression profile during epithelial wound repair in bronchial epithelial cellsAleksandra Szczepankiewicz, Peter M Lackie, John W Holloway
Atherosclerosis|September 6, 2003
TLR4 Asp299Gly polymorphism is not associated with coronary artery stenosisIan A Yang, John W Holloway, Shu Ye, et al.
Pageof 27